Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 6/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1065506 | 0.88 | TP53 (0.64) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL1066761 | 0.86 | CYP1A2 (0.71) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL18166723 | 0.85 | CYP1A2 (0.69) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL18166598 | 0.85 | RXFP1 (0.71) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL1064795 | 0.83 | CYP1A2 (0.73) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL18166656 | 0.83 | RXFP1 (0.68) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL5462777 | 0.82 | RXFP1 (0.78) | CYP1A2CYP3A4THRBRXFP1MAPK1 | |
| SCHEMBL12584444 | 0.82 | CYP1A2 (0.71) | POLBCYP1A2CYP3A4THRBRXFP1 | |
| SCHEMBL1067104 | 0.81 | CYP1A2 (0.69) | CYP1A2CYP3A4RXFP1MAPK1TP53 | |
| SCHEMBL18166567 | 0.80 | RXFP1 (0.61) | CYP1A2CYP3A4RXFP1MAPK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663295-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | ELI LILLY AND CO. (US) | 2020-06-10 | — | — | EP | disclosed |
| EP-3184527-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | Hydra Biosciences, Inc. (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2170309-B1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | HYDRA BIOSCIENCES INC (US) | 2016-10-26 | — | — | EP | disclosed |